Sana Biotechnology, Inc. (SANA)
3.78
-0.13
(-3.32%)
USD |
NASDAQ |
Aug 24, 16:00
3.785
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Shareholders Equity (Quarterly) : 154.57M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 154.57M |
| March 31, 2026 | 119.24M |
| December 31, 2025 | 160.88M |
| September 30, 2025 | 195.31M |
| June 30, 2025 | 122.56M |
| March 31, 2025 | 209.08M |
| December 31, 2024 | 250.50M |
| September 30, 2024 | 292.48M |
| June 30, 2024 | 339.65M |
| March 31, 2024 | 375.14M |
| December 31, 2023 | 287.51M |
| September 30, 2023 | 365.85M |
| June 30, 2023 | 355.03M |
| March 31, 2023 | 428.26M |
| Date | Value |
|---|---|
| December 31, 2022 | 499.32M |
| September 30, 2022 | 566.02M |
| June 30, 2022 | 639.50M |
| March 31, 2022 | 701.66M |
| December 31, 2021 | 728.50M |
| September 30, 2021 | 830.08M |
| June 30, 2021 | 905.90M |
| March 31, 2021 | 881.98M |
| December 31, 2020 | 431.71M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 274.82M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Twist Bioscience Corp. | 445.74M |
| Beam Therapeutics, Inc. | 1.067B |
| Prime Medicine, Inc. | 39.81M |
| Intellia Therapeutics, Inc. | 727.71M |
| Moderna, Inc. | 6.761B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 431.52M |
| Total Liabilities (Quarterly) | 276.95M |
| Debt to Equity Ratio | 0.4771 |
| Current Ratio | 1.379 |
| Net Debt Paydown Yield | 0.34% |